Sg3 Management, LLC Novo Cure LTD Put Options Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $56,440 - $118,810	-1,000 Closed	0 $0
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $345,492 - $460,998	5,400 Added 540.0%	6,400 $469,000
Q3 2022 May 15, 2023	SELL	$67.99 - $89.57 $367,146 - $483,677	-5,400 Reduced 84.38%	1,000 $75,000
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $1.14 Million - $1.61 Million	-19,000 Reduced 95.0%	1,000 $83,000
Q4 2021 Feb 15, 2022	BUY	$75.08 - $121.99 $750,800 - $1.22 Million	10,000 Added 100.0%	20,000 $1.5 Million
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $5.63 Million - $9.44 Million	-48,500 Reduced 82.91%	10,000 $1.16 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $7.63 Million - $13.2 Million	58,500 New	58,500 $13 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.15B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.